Keywords
Low-Level Light Therapy
Down Syndrome
Lymphoid Leukemia
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To report a clinical case using Photobiomodulation (FBM) in the treatment of oral mucositis (OM) in a 15-year-old patient with Down syndrome (DS) and acute lymphoblastic leukemia (ALL), detailing the treatment performed and the conclusion of the case. Case Details: A 15-year-old white female patient was admitted to the Alcides Carneiro University Hospital, diagnosed with ALL and undergoing high-dose methotrexate chemotherapy. She developed OM, manifesting painful oral lesions that hindered her ability to eat. As treatment, FBM therapy was initiated, adjusting the approach according to the patient's varying levels of cooperation. After a few sessions, significant improvement in the healing of the lesions and reduction in pain was observed, allowing her to resume oral feeding without significant discomfort. Final Considerations: The clinical experience observed in this study underscores the relevance and importance of using FBM as a valuable intervention for managing OM in vulnerable patients, including those with DS undergoing chemotherapy.
References
AL-ANSARI S, et al. Oral mucositis induced by anticancer therapies. Current oral health reports, 2015; 2: 202-211.
AMADORI F, et al. Low-level laser therapy for treatment of chemotherapy-induced oral mucositis in childhood: a randomized double-blind controlled study. Lasers in medical science, 2016; 31: 1231-1236.
AMARO JS, et al. Fotobiomodulação como tratamento auxiliar de mucosite oral em pacientes submetidos a tratamentos antineoplásicos: revisão integrativa. Research, Society and Development, 2022; 11(8): e15511830827.
BASSO FG, et al. Biomodulation of inflammatory cytokines related to oral mucositis by low‐level laser therapy. Photochemistry and photobiology, 2015; 91(4): 952-956.
CHIANG JC, et al. Trisomy silencing by XIST normalizes Down syndrome cell pathogenesis demonstrated for hematopoietic defects in vitro. Nature communications, 2018; 9(1): 5180.
CHUNG H, et al. The nuts and bolts of low-level laser (light) therapy. Annals of biomedical engineering, 2012; 40: 516-533.
CRUZ LB, et al. Influence of low‐energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy. Pediatric blood & cancer, 2007; 48(4): 435-440.
DE CASTRO JFL, et al. Low-level laser in prevention and treatment of oral mucositis in pediatric patients with acute lymphoblastic leukemia. Photomedicine and Laser surgery, 2013; 31(12): 613-618.
GOBBO M, et al. Multicenter randomized, double‐blind controlled trial to evaluate the efficacy of laser therapy for the treatment of severe oral mucositis induced by chemotherapy in children: laMPO RCT. Pediatric blood & cancer, 2018; 65(8): e27098.
KUHN A, et al. Low-level infrared laser therapy in chemotherapy-induced oral mucositis: a randomized placebo-controlled trial in children. Journal of pediatric hematology/oncology, 2009; 31(1): 33-37.
LAURENT AP, KOTECHA RS, MALINGE S. Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome. Leukemia, 2020; 34(8): 1984-1999.
LIAO W, LIU Y. Treatment outcomes in children with Acute lymphoblastic leukemia with versus without coexisting Down's syndrome: a systematic review and meta-analysis. Medicine, 2020; 99(29): e21015.
MAZHARI F, SHIRAZI AS, SHABZENDEHDAR M. Management of oral mucositis in pediatric patients receiving cancer therapy: A systematic review and meta‐analysis. Pediatric Blood & Cancer, 2019; 66(3): e27403.
MURPHY BR, et al. Development of acute lymphoblastic leukemia following treatment for acute myeloid leukemia in children with Down syndrome: A case report and retrospective review of Children's Oncology Group acute myeloid leukemia trials. Pediatric blood & cancer, 2019; 66(8): e27700.
PERALTA-MAMANI M, et al. Low-level laser therapy dosimetry most used for oral mucositis due to radiotherapy for head and neck cancer: a systematic review and meta-analysis. Critical Reviews in Oncology/Hematology, 2019; 138: 14-23.
REDMAN MG, HARRIS K, PHILLIPS BS. Low-level laser therapy for oral mucositis in children with cancer. Archives of Disease in Childhood, 2022; 107(2): 128-133.
REYAD FA, ELSAYED NM, EL CHAZLI Y. Photobiomodulation for chemotherapy‐induced oral mucositis in leukemic children: A randomized controlled clinical trial. Oral diseases, 2023; 29(5): 2239-2247.
REZK-ALLAH SS, et al. Effect of low-level laser therapy in treatment of chemotherapy induced oral mucositis. Journal of lasers in medical sciences, 2019; 10(2): 125.
ROBERTS KG. Genetics and prognosis of ALL in children vs adults. Hematology 2014, The American Society of Hematology Education Program Book, 2018; 2018(1): 137-145.
SONIS ST, et al. Perspectives on cancer therapy‐induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer: Interdisciplinary International Journal of the American Cancer Society, 2004; 100(S9): 1995-2025.
SUNG L, et al. Guideline for the prevention of oral and oropharyngeal mucositis in children receiving treatment for cancer or undergoing haematopoietic stem cell transplantation. BMJ supportive & palliative care, 2017; 7(1): 7-16.
ZIPURSKY A. Susceptibility to leukemia and resistance to solid tumors in Down syndrome. Pediatric research, 2000; 47(6): 704.